The landscape is actively changing
Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly prescribed for weight management in the UK
By managing different aspects of male sex function, blood flow, inflammation, tissue recovery, and nerve protection, therapy with this medicine can advance the productivity of existing clinical interventions
Severe nausea requiring medication discontinuation affects approximately 2-4% of users
The honest takeaway: MIC injections are not a shortcut to fat loss, and they are not FDA-approved for that purpose
The median vitamin B12 was 342 (266, 446) pg/mL